ABSTRACT

Cancer is an existence-threatening disease, ensuing in almost 10 million deaths global. There are various reasons of most cancers, and the prognostic statistics varies in every patient because of specific molecular signatures in the human body. However, genetic heterogeneity takes area due to wonderful cancer sorts and changes within the neoplasms, which complicates the evaluation and treatment. Targeted drug shipping is taken into consideration a pivotal contributor to precision medication for maximum cancers treatments as this technique allows supply medication to sufferers through using systematically increasing the drug cognizance on the targeted frame elements. In such times, nanoparticle mediated drug shipping and the combination of Artificial intelligence (AI) can assist bridge the space and decorate localized drug delivery systems capable of biomarker sensing. Keywords: Artificial intelligence, Targeted drug delivery systems, nanoparticles, cancer therapy, Bioavalability, Biomarkers
Publication date: 01/12/2024

https://ijbpas.com/pdf/2024/December/MS_IJBPAS_2024_8505.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.12.8505